Double refractory Multiple myeloma is defined as d...

Chronic lymphocytic leukemia (CLL) is a type of bl...

New modality for treatment against cancer is Immun...

Question- Is it possible to cure CML (CHRONIC MYEL...

Bevacizumab is the first antiangiogenic therapy to...

Maintenance with PARP inhibitor is the way forward...

Median survival in metastatic carcinoma breast is ...

IMMUNOTHERAPY IN LUNG CANCER- THE FUTURE OF CANCER...